Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,547 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02258087 | HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer.(PROMOBRA) | unknown | Phase 2 / Phase 3 | 50 | National Institute of Oncology, HungaryOTHER | 1 | Oct 7, 2014 | clinicaltrials |
| NCT01355185 | Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences | unknown | — | 20 | AHS Cancer Control AlbertaOTHER | 1 | Oct 3, 2014 |
| clinicaltrials |
| NCT02233725 | MRI / Ultrasound Fusion With Contrast-Enhanced Ultrasound Guidance | unknown | Phase 1 | 50 | University of British ColumbiaOTHER | 1 | Sep 8, 2014 | clinicaltrials |
| NCT01842750 | The Use of Rectal Balloons in Radical Pelvic Radiotherapy - a Feasibility Study(BRAD) | unknown | N/A | 10 | The Christie NHS Foundation TrustOTHER | 1 | Jul 30, 2014 | clinicaltrials |
| NCT01726894 | Focal Therapy for Localised Prostate Cancer Using Irreversible Electroporation(Nano) | unknown | N/A | 20 | University College London HospitalsOTHER | 1 | Jun 18, 2014 | clinicaltrials |
| NCT02145494 | The SPARC Trial: Stereotactic Prostate Ablative Radiotherapy Using Cyberknife(SPARC) | unknown | Phase 2 | 20 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 23, 2014 | clinicaltrials |
| NCT02138760 | Comparison of MRI Fusion Biopsy Techniques in Men With Elevated PSA and Prior Negative Prostate Biopsy | unknown | N/A | 400 | Kaiser PermanenteOTHER | 1 | May 15, 2014 | clinicaltrials |
| NCT00452556 | The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study | unknown | Phase 2 | 86 | Nova Scotia Cancer CentreOTHER | 1 | Mar 19, 2014 | clinicaltrials |
| NCT00175396 | Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy | unknown | Phase 3 | 400 | University of British ColumbiaOTHER | 1 | Mar 17, 2014 | clinicaltrials |
| NCT02070952 | CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer | unknown | N/A | 167 | Riverside Community Hospital, CaliforniaOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT00295802 | Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer | unknown | Phase 2 / Phase 3 | 141 | EDAP TMS S.A.INDUSTRY | 2 | Feb 7, 2014 | clinicaltrials |
| NCT02041559 | The Effect of Different Doses of Remifentanil on Kidney Function During Robot Assisted Prostatectomy - A Retrospective Study | unknown | — | 1,500 | Yonsei UniversityOTHER | 1 | Jan 22, 2014 | clinicaltrials |
| NCT02037464 | CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer(CAPSAICIN) | unknown | Phase 2 | 100 | Sunnybrook Health Sciences CentreOTHER | 1 | Jan 16, 2014 | clinicaltrials |
| NCT00967954 | Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer | unknown | N/A | 120 | Cancer Research UKOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00002775 | Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 1 / Phase 2 | 37 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00003633 | Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer | unknown | Phase 1 | 12 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003717 | Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 2 | 17 | St. Barnabas Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00024063 | SU006668 in Treating Patients With Advanced Solid Tumors | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Dec 19, 2013 | clinicaltrials |
| NCT00045123 | R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence | unknown | Phase 2 | — | Myrexis Inc.INDUSTRY | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00684970 | Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)(TLH-202) | unknown | Phase 2 | 100 | Tiltan Pharma Ltd.INDUSTRY | 1 | Dec 5, 2013 | clinicaltrials |
| NCT01938339 | Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer | unknown | N/A | 60 | Seoul National University HospitalOTHER | 1 | Dec 5, 2013 | clinicaltrials |
| NCT00003183 | Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 1 / Phase 2 | 64 | Hope Cancer Institute, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00005960 | Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | unknown | Phase 2 | — | AmgenINDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00005939 | Brachytherapy in Treating Patients With Recurrent Prostate Cancer | unknown | Phase 1 / Phase 2 | — | Center for Molecular MedicineOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00348998 | Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | unknown | Phase 2 | 18 | Virginia Mason Hospital/Medical CenterOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00009750 | Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | unknown | Phase 1 | — | University of California, DavisOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00322114 | Lycopene in Preventing Prostate Cancer in Healthy Participants | unknown | N/A | 150 | University of Illinois at ChicagoOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00354497 | Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men | unknown | Phase 2 | 800 | Lawrence Livermore National Laboratory at University of CaliforniaOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00503646 | Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners | unknown | N/A | 100 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00363285 | Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer | unknown | Phase 3 | 900 | St. Bartholomew's HospitalOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00376792 | Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer | unknown | Phase 3 | 396 | Scandinavian Prostate Cancer GroupNETWORK | 5 | Aug 26, 2013 | clinicaltrials |
| NCT00601406 | Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | unknown | N/A | 2,200 | The Christie NHS Foundation TrustOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00758173 | Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom | unknown | — | 2,000 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00946543 | Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer | unknown | Phase 1 | 198 | Royal Marsden NHS Foundation TrustOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00959023 | Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer | unknown | — | 21,000 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00987675 | High-Intensity Focused Ultrasound Ablation in Treating Patients With Progressive Prostate Cancer | unknown | Phase 2 | 26 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00988130 | High-Intensity Focused Ultrasound Focal Ablation in Treating Patients With Progressive Prostate Cancer | unknown | Phase 2 | 26 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01177865 | Study of Treatment Choice in Patients With Localized Prostate Cancer | unknown | N/A | 432 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01193855 | Dutasteride in Treating Patients With Prostate Cancer | unknown | Phase 2 | 42 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00796458 | Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer | unknown | Phase 3 | 200 | A.O.U. San Giovanni Battista di Torino, ItalyOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00967889 | Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer | unknown | — | — | Cancer Research UKOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00005992 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00110162 | Androgen Deprivation Therapy in Treating Patients With Prostate Cancer | unknown | Phase 3 | 2,000 | Peter MacCallum Cancer Centre, AustraliaOTHER | 2 | Aug 7, 2013 | clinicaltrials |
| NCT01292291 | MRI in Diagnosing Prostate Cancer | unknown | N/A | 714 | University College London HospitalsOTHER | 0 | Aug 7, 2013 | clinicaltrials |
| NCT01909388 | Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy(BRAPROST) | unknown | Phase 2 | 15 | Alfonso Gomez-IturriagaOTHER | 1 | Jul 26, 2013 | clinicaltrials |
| NCT01826565 | Comparison of Two Insertion Technique of I-gel(I-gel90) | unknown | N/A | 100 | Seoul National University HospitalOTHER | 0 | May 6, 2013 | clinicaltrials |
| NCT01839994 | Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer | unknown | Phase 3 | 350 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Apr 25, 2013 | clinicaltrials |
| NCT01814150 | The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel | unknown | — | 200 | Gottfried MayaOTHER | 1 | Mar 25, 2013 | clinicaltrials |
| NCT01379742 | Comparison of Between ThinSeed™ and OncoSeed™ for Permanent Prostate Brachytherapy | unknown | Phase 4 | 240 | Prostate Cancer Foundation of ChicagoOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT01769950 | Choline-PET for Evaluating the Incidence of Nodal Metastases Among Newly Diagnosed Patients of Prostate Cancer(ChoPEN) | unknown | N/A | 120 | Bangalore Institute of OncologyOTHER | 1 | Jan 17, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Oct 7, 2014source: clinicaltrials